
@ShahidNShah
AI deploys applications that mimic human-level intelligence, while machine learning (ML) is the subset of those applications. Grand View Research estimates that the market for artificial intelligence (AI) in healthcare was worth USD 15.4 billion in 2022 and is projected to increase to USD 208.2 billion by 2030 at a projected CAGR of 37.5%. That's a remarkable growth rate, reflecting the predicted value delivery to the healthcare market's largely early-phase use of AI. Given the predicted growth in the health sector, many professionals may wonder why they have not yet looked into AI. Machine learning (ML) is a subset of those applications that are not explicitly programmed or learnt, whereas artificial intelligence (AI) uses applications that resemble human-level intelligence. Together, these quickly developing technologies are boosting productivity and efficiency in a variety of industrial manufacturing.
Artificial intelligence (AI) has the potential to significantly transform the pharmaceutical and medical device markets in several ways:
Overall, AI has the potential to improve the efficiency, effectiveness, and accuracy of the pharmaceutical and medical device markets, leading to better patient outcomes and reduced healthcare costs.
Continue reading at hitconsultant.net
AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring. In order to commercialise its Parky Parkinson's …
Posted May 2, 2023 Digital Monitoring Chronic Disease Digital Therapeutics
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Apr 16, 2025 at 5:55am